Gates Foundation encourages better access to vet meds; Lilly licenses drug to treat blood disorders; PrimeGen jumps into animal health;

> The Bill & Melinda Gates Foundation funded the 4th annual Global Animal Health Conference, an event in Tanzania sponsored by HealthforAnimals that brought together a range of experts to discuss methods for increasing access to veterinary medicines in emerging countries. Release

> Eli Lilly's ($LLY) Elanco Animal Health has licensed the rights to develop Actinobac Biomed's lead drug candidate, Leukothera, to treat companion and food animals who suffer from diseases that affect white blood cells. Release

> PrimeGen Biotech, which is developing stem cell treatments, announced it has opened a subsidiary focused on animal health, VetCell Therapeutics, which will operate out of its newly opened research facility in Santa Ana, CA. Release

> Veterinary imaging supplier Universal Medical has formed an educational partnership with Veterinary Professional Development, which organizes continuing-education classes for practitioners. Release

> MediVet Biologics has added Merritt Veterinary Supplies as a distribution supplier of its adipose-derived stem cell products and services. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…